Medical Isotopes Industry Research Report 2023

Medical Isotopes Industry Research Report 2023


A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.

Highlights

The global Medical Isotopes market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a 'cold' process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.
North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medical Isotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Isotopes.
The Medical Isotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Isotopes market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Isotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science

Product Type Insights

Global markets are presented by Medical Isotopes type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Medical Isotopes are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Medical Isotopes segment by Type

Stable Isotopes
Radioisotopes

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Medical Isotopes market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Medical Isotopes market.
Medical Isotopes Segment by Application

Nuclear Therapy
Equipment Radioactive Source
Diagnosis

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medical Isotopes market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Isotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Medical Isotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Medical Isotopes industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Isotopes.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Isotopes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Medical Isotopes by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Stable Isotopes
1.2.3 Radioisotopes
2.3 Medical Isotopes by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Nuclear Therapy
2.3.3 Equipment Radioactive Source
2.3.4 Diagnosis
2.4 Assumptions and Limitations
3 Medical Isotopes Breakdown Data by Type
3.1 Global Medical Isotopes Historic Market Size by Type (2018-2023)
3.2 Global Medical Isotopes Forecasted Market Size by Type (2023-2028)
4 Medical Isotopes Breakdown Data by Application
4.1 Global Medical Isotopes Historic Market Size by Application (2018-2023)
4.2 Global Medical Isotopes Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Medical Isotopes Market Perspective (2018-2029)
5.2 Global Medical Isotopes Growth Trends by Region
5.2.1 Global Medical Isotopes Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Medical Isotopes Historic Market Size by Region (2018-2023)
5.2.3 Medical Isotopes Forecasted Market Size by Region (2024-2029)
5.3 Medical Isotopes Market Dynamics
5.3.1 Medical Isotopes Industry Trends
5.3.2 Medical Isotopes Market Drivers
5.3.3 Medical Isotopes Market Challenges
5.3.4 Medical Isotopes Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Medical Isotopes Players by Revenue
6.1.1 Global Top Medical Isotopes Players by Revenue (2018-2023)
6.1.2 Global Medical Isotopes Revenue Market Share by Players (2018-2023)
6.2 Global Medical Isotopes Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Medical Isotopes Head office and Area Served
6.4 Global Medical Isotopes Players, Product Type & Application
6.5 Global Medical Isotopes Players, Date of Enter into This Industry
6.6 Global Medical Isotopes Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Medical Isotopes Market Size (2018-2029)
7.2 North America Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Medical Isotopes Market Size by Country (2018-2023)
7.4 North America Medical Isotopes Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Medical Isotopes Market Size (2018-2029)
8.2 Europe Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Medical Isotopes Market Size by Country (2018-2023)
8.4 Europe Medical Isotopes Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Medical Isotopes Market Size (2018-2029)
9.2 Asia-Pacific Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Medical Isotopes Market Size by Country (2018-2023)
9.4 Asia-Pacific Medical Isotopes Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Medical Isotopes Market Size (2018-2029)
10.2 Latin America Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Medical Isotopes Market Size by Country (2018-2023)
10.4 Latin America Medical Isotopes Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Medical Isotopes Market Size (2018-2029)
11.2 Middle East & Africa Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Medical Isotopes Market Size by Country (2018-2023)
11.4 Middle East & Africa Medical Isotopes Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 NRG
11.1.1 NRG Company Detail
11.1.2 NRG Business Overview
11.1.3 NRG Medical Isotopes Introduction
11.1.4 NRG Revenue in Medical Isotopes Business (2017-2022)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Detail
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Medical Isotopes Introduction
11.2.4 NTP Radioisotopes Revenue in Medical Isotopes Business (2017-2022)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Detail
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Medical Isotopes Introduction
11.3.4 JSC Isotope Revenue in Medical Isotopes Business (2017-2022)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Detail
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Medical Isotopes Introduction
11.4.4 ANSTO Revenue in Medical Isotopes Business (2017-2022)
11.4.5 ANSTO Recent Development
11.5 IRE
11.5.1 IRE Company Detail
11.5.2 IRE Business Overview
11.5.3 IRE Medical Isotopes Introduction
11.5.4 IRE Revenue in Medical Isotopes Business (2017-2022)
11.5.5 IRE Recent Development
11.6 Nordion
11.6.1 Nordion Company Detail
11.6.2 Nordion Business Overview
11.6.3 Nordion Medical Isotopes Introduction
11.6.4 Nordion Revenue in Medical Isotopes Business (2017-2022)
11.6.5 Nordion Recent Development
11.7 Curium Pharma
11.7.1 Curium Pharma Company Detail
11.7.2 Curium Pharma Business Overview
11.7.3 Curium Pharma Medical Isotopes Introduction
11.7.4 Curium Pharma Revenue in Medical Isotopes Business (2017-2022)
11.7.5 Curium Pharma Recent Development
11.8 Cambridge Isotope Laboratories
11.8.1 Cambridge Isotope Laboratories Company Detail
11.8.2 Cambridge Isotope Laboratories Business Overview
11.8.3 Cambridge Isotope Laboratories Medical Isotopes Introduction
11.8.4 Cambridge Isotope Laboratories Revenue in Medical Isotopes Business (2017-2022)
11.8.5 Cambridge Isotope Laboratories Recent Development
11.9 Eckert & Ziegler Strahlen
11.9.1 Eckert & Ziegler Strahlen Company Detail
11.9.2 Eckert & Ziegler Strahlen Business Overview
11.9.3 Eckert & Ziegler Strahlen Medical Isotopes Introduction
11.9.4 Eckert & Ziegler Strahlen Revenue in Medical Isotopes Business (2017-2022)
11.9.5 Eckert & Ziegler Strahlen Recent Development
11.10 Polatom
11.10.1 Polatom Company Detail
11.10.2 Polatom Business Overview
11.10.3 Polatom Medical Isotopes Introduction
11.10.4 Polatom Revenue in Medical Isotopes Business (2017-2022)
11.10.5 Polatom Recent Development
11.11 Center of Molecular Research
11.11.1 Center of Molecular Research Company Detail
11.11.2 Center of Molecular Research Business Overview
11.11.3 Center of Molecular Research Medical Isotopes Introduction
11.11.4 Center of Molecular Research Revenue in Medical Isotopes Business (2017-2022)
11.11.5 Center of Molecular Research Recent Development
11.12 China National Nuclear Corporation
11.12.1 China National Nuclear Corporation Company Detail
11.12.2 China National Nuclear Corporation Business Overview
11.12.3 China National Nuclear Corporation Medical Isotopes Introduction
11.12.4 China National Nuclear Corporation Revenue in Medical Isotopes Business (2017-2022)
11.12.5 China National Nuclear Corporation Recent Development
11.13 Urenco
11.13.1 Urenco Company Detail
11.13.2 Urenco Business Overview
11.13.3 Urenco Medical Isotopes Introduction
11.13.4 Urenco Revenue in Medical Isotopes Business (2017-2022)
11.13.5 Urenco Recent Development
11.14 LANL
11.14.1 LANL Company Detail
11.14.2 LANL Business Overview
11.14.3 LANL Medical Isotopes Introduction
11.14.4 LANL Revenue in Medical Isotopes Business (2017-2022)
11.14.5 LANL Recent Development
11.15 Shanghai Engineering Research Center
11.15.1 Shanghai Engineering Research Center Company Detail
11.15.2 Shanghai Engineering Research Center Business Overview
11.15.3 Shanghai Engineering Research Center Medical Isotopes Introduction
11.15.4 Shanghai Engineering Research Center Revenue in Medical Isotopes Business (2017-2022)
11.15.5 Shanghai Engineering Research Center Recent Development
11.16 IDB Holland
11.16.1 IDB Holland Company Detail
11.16.2 IDB Holland Business Overview
11.16.3 IDB Holland Medical Isotopes Introduction
11.16.4 IDB Holland Revenue in Medical Isotopes Business (2017-2022)
11.16.5 IDB Holland Recent Development
11.17 NHTC
11.17.1 NHTC Company Detail
11.17.2 NHTC Business Overview
11.17.3 NHTC Medical Isotopes Introduction
11.17.4 NHTC Revenue in Medical Isotopes Business (2017-2022)
11.17.5 NHTC Recent Development
11.18 Linde
11.18.1 Linde Company Detail
11.18.2 Linde Business Overview
11.18.3 Linde Medical Isotopes Introduction
11.18.4 Linde Revenue in Medical Isotopes Business (2017-2022)
11.18.5 Linde Recent Development
11.19 ORNL
11.19.1 ORNL Company Detail
11.19.2 ORNL Business Overview
11.19.3 ORNL Medical Isotopes Introduction
11.19.4 ORNL Revenue in Medical Isotopes Business (2017-2022)
11.19.5 ORNL Recent Development
11.20 SI Science
11.20.1 SI Science Company Detail
11.20.2 SI Science Business Overview
11.20.3 SI Science Medical Isotopes Introduction
11.20.4 SI Science Revenue in Medical Isotopes Business (2017-2022)
11.20.5 SI Science Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Medical Isotopes Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Medical Isotopes Revenue Market Share by Type (2018-2023)
Table 7. Global Medical Isotopes Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Medical Isotopes Revenue Market Share by Type (2024-2029)
Table 9. Global Medical Isotopes Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Medical Isotopes Revenue Market Share by Application (2018-2023)
Table 11. Global Medical Isotopes Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Medical Isotopes Revenue Market Share by Application (2024-2029)
Table 13. Global Medical Isotopes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Medical Isotopes Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Medical Isotopes Market Share by Region (2018-2023)
Table 16. Global Medical Isotopes Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Medical Isotopes Market Share by Region (2024-2029)
Table 18. Medical Isotopes Market Trends
Table 19. Medical Isotopes Market Drivers
Table 20. Medical Isotopes Market Challenges
Table 21. Medical Isotopes Market Restraints
Table 22. Global Top Medical Isotopes Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Medical Isotopes Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Medical Isotopes Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Medical Isotopes, Headquarters and Area Served
Table 26. Global Medical Isotopes Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Medical Isotopes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Medical Isotopes Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Medical Isotopes Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Medical Isotopes Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Medical Isotopes Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Medical Isotopes Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Medical Isotopes Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Medical Isotopes Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Medical Isotopes Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Medical Isotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Medical Isotopes Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Medical Isotopes Market Size by Country (2024-2029) & (US$ Million)
Table 45. NRG Company Detail
Table 46. NRG Business Overview
Table 47. NRG Medical Isotopes Product
Table 48. NRG Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 49. NRG Recent Development
Table 50. NTP Radioisotopes Company Detail
Table 51. NTP Radioisotopes Business Overview
Table 52. NTP Radioisotopes Medical Isotopes Product
Table 53. NTP Radioisotopes Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 54. NTP Radioisotopes Recent Development
Table 55. JSC Isotope Company Detail
Table 56. JSC Isotope Business Overview
Table 57. JSC Isotope Medical Isotopes Product
Table 58. JSC Isotope Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 59. JSC Isotope Recent Development
Table 60. ANSTO Company Detail
Table 61. ANSTO Business Overview
Table 62. ANSTO Medical Isotopes Product
Table 63. ANSTO Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 64. ANSTO Recent Development
Table 65. IRE Company Detail
Table 66. IRE Business Overview
Table 67. IRE Medical Isotopes Product
Table 68. IRE Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 69. IRE Recent Development
Table 70. Nordion Company Detail
Table 71. Nordion Business Overview
Table 72. Nordion Medical Isotopes Product
Table 73. Nordion Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 74. Nordion Recent Development
Table 75. Curium Pharma Company Detail
Table 76. Curium Pharma Business Overview
Table 77. Curium Pharma Medical Isotopes Product
Table 78. Curium Pharma Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 79. Curium Pharma Recent Development
Table 80. Cambridge Isotope Laboratories Company Detail
Table 81. Cambridge Isotope Laboratories Business Overview
Table 82. Cambridge Isotope Laboratories Medical Isotopes Product
Table 83. Cambridge Isotope Laboratories Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 84. Cambridge Isotope Laboratories Recent Development
Table 85. Eckert & Ziegler Strahlen Company Detail
Table 86. Eckert & Ziegler Strahlen Business Overview
Table 87. Eckert & Ziegler Strahlen Medical Isotopes Product
Table 88. Eckert & Ziegler Strahlen Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 89. Eckert & Ziegler Strahlen Recent Development
Table 90. Polatom Company Detail
Table 91. Polatom Business Overview
Table 92. Polatom Medical Isotopes Product
Table 93. Polatom Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 94. Polatom Recent Development
Table 95. Center of Molecular Research Company Detail
Table 96. Center of Molecular Research Business Overview
Table 97. Center of Molecular Research Medical IsotopesProduct
Table 98. Center of Molecular Research Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 99. Center of Molecular Research Recent Development
Table 100. China National Nuclear Corporation Company Detail
Table 101. China National Nuclear Corporation Business Overview
Table 102. China National Nuclear Corporation Medical IsotopesProduct
Table 103. China National Nuclear Corporation Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 104. China National Nuclear Corporation Recent Development
Table 105. Urenco Company Detail
Table 106. Urenco Business Overview
Table 107. Urenco Medical IsotopesProduct
Table 108. Urenco Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 109. Urenco Recent Development
Table 110. LANL Company Detail
Table 111. LANL Business Overview
Table 112. LANL Medical IsotopesProduct
Table 113. LANL Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 114. LANL Recent Development
Table 115. Shanghai Engineering Research Center Company Detail
Table 116. Shanghai Engineering Research Center Business Overview
Table 117. Shanghai Engineering Research Center Medical IsotopesProduct
Table 118. Shanghai Engineering Research Center Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 119. Shanghai Engineering Research Center Recent Development
Table 120. IDB Holland Company Detail
Table 121. IDB Holland Business Overview
Table 122. IDB Holland Medical IsotopesProduct
Table 123. IDB Holland Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 124. IDB Holland Recent Development
Table 125. NHTC Company Detail
Table 126. NHTC Business Overview
Table 127. NHTC Medical IsotopesProduct
Table 128. NHTC Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 129. NHTC Recent Development
Table 130. Linde Company Detail
Table 131. Linde Business Overview
Table 132. Linde Medical IsotopesProduct
Table 133. Linde Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 134. Linde Recent Development
Table 135. ORNL Company Detail
Table 136. ORNL Business Overview
Table 137. ORNL Medical IsotopesProduct
Table 138. ORNL Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 139. ORNL Recent Development
Table 140. SI Science Company Detail
Table 141. SI Science Business Overview
Table 142. SI Science Medical IsotopesProduct
Table 143. SI Science Revenue in Medical Isotopes Business (2017-2022) & (US$ Million)
Table 144. SI Science Recent Development
Table 145. NRG Company Information
Table 146. NRG Business Overview
Table 147. NRG Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 148. NRG Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 149. NRG Recent Development
Table 150. NTP Radioisotopes Company Information
Table 151. NTP Radioisotopes Business Overview
Table 152. NTP Radioisotopes Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 153. NTP Radioisotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 154. NTP Radioisotopes Recent Development
Table 155. JSC Isotope Company Information
Table 156. JSC Isotope Business Overview
Table 157. JSC Isotope Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 158. JSC Isotope Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 159. JSC Isotope Recent Development
Table 160. ANSTO Company Information
Table 161. ANSTO Business Overview
Table 162. ANSTO Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 163. ANSTO Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 164. ANSTO Recent Development
Table 165. IRE Company Information
Table 166. IRE Business Overview
Table 167. IRE Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 168. IRE Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 169. IRE Recent Development
Table 170. Nordion Company Information
Table 171. Nordion Business Overview
Table 172. Nordion Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 173. Nordion Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 174. Nordion Recent Development
Table 175. Curium Pharma Company Information
Table 176. Curium Pharma Business Overview
Table 177. Curium Pharma Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 178. Curium Pharma Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 179. Curium Pharma Recent Development
Table 180. Cambridge Isotope Laboratories Company Information
Table 181. Cambridge Isotope Laboratories Business Overview
Table 182. Cambridge Isotope Laboratories Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 183. Cambridge Isotope Laboratories Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 184. Cambridge Isotope Laboratories Recent Development
Table 185. Eckert & Ziegler Strahlen Company Information
Table 186. Eckert & Ziegler Strahlen Business Overview
Table 187. Eckert & Ziegler Strahlen Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 188. Eckert & Ziegler Strahlen Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 189. Eckert & Ziegler Strahlen Recent Development
Table 190. Polatom Company Information
Table 191. Polatom Business Overview
Table 192. Polatom Medical Isotopes Revenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 193. Polatom Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 194. Polatom Recent Development
Table 195. Center of Molecular Research Company Information
Table 196. Center of Molecular Research Business Overview
Table 197. Center of Molecular Research Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 198. Center of Molecular Research Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 199. Center of Molecular Research Recent Development
Table 200. China National Nuclear Corporation Company Information
Table 201. China National Nuclear Corporation Business Overview
Table 202. China National Nuclear Corporation Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 203. China National Nuclear Corporation Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 204. China National Nuclear Corporation Recent Development
Table 205. Urenco Company Information
Table 206. Urenco Business Overview
Table 207. Urenco Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 208. Urenco Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 209. Urenco Recent Development
Table 210. LANL Company Information
Table 211. LANL Business Overview
Table 212. LANL Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 213. LANL Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 214. LANL Recent Development
Table 215. Shanghai Engineering Research Center Company Information
Table 216. Shanghai Engineering Research Center Business Overview
Table 217. Shanghai Engineering Research Center Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 218. Shanghai Engineering Research Center Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 219. Shanghai Engineering Research Center Recent Development
Table 220. IDB Holland Company Information
Table 221. IDB Holland Business Overview
Table 222. IDB Holland Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 223. IDB Holland Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 224. IDB Holland Recent Development
Table 225. NHTC Company Information
Table 226. NHTC Business Overview
Table 227. NHTC Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 228. NHTC Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 229. NHTC Recent Development
Table 230. Linde Company Information
Table 231. Linde Business Overview
Table 232. Linde Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 233. Linde Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 234. Linde Recent Development
Table 235. ORNL Company Information
Table 236. ORNL Business Overview
Table 237. ORNL Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 238. ORNL Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 239. ORNL Recent Development
Table 240. SI Science Company Information
Table 241. SI Science Business Overview
Table 242. SI Science Medical IsotopesRevenue in Medical Isotopes Business (2018-2023) & (US$ Million)
Table 243. SI Science Revenue in Medical Isotopes Business (2018-2023) & (US$ Million) Portfolio
Table 244. SI Science Recent Development
Table 245. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Medical Isotopes Product Picture
Figure 5. Global Medical Isotopes Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Medical Isotopes Market Share by Type: 2022 VS 2029
Figure 7. Stable Isotopes Product Picture
Figure 8. Radioisotopes Product Picture
Figure 9. Global Medical Isotopes Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Medical Isotopes Market Share by Application: 2022 VS 2029
Figure 11. Nuclear Therapy Product Picture
Figure 12. Equipment Radioactive Source Product Picture
Figure 13. Diagnosis Product Picture
Figure 14. Global Medical Isotopes Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Medical Isotopes Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Medical Isotopes Market Share by Region: 2022 VS 2029
Figure 17. Global Medical Isotopes Market Share by Players in 2022
Figure 18. Global Medical Isotopes Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Medical Isotopes Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Medical Isotopes Market Share by Country (2018-2029)
Figure 23. United States Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Medical Isotopes Market Share by Country (2018-2029)
Figure 27. Germany Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Medical Isotopes Market Share by Country (2018-2029)
Figure 35. China Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Medical Isotopes Market Share by Country (2018-2029)
Figure 43. Mexico Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Medical Isotopes Market Share by Country (2018-2029)
Figure 47. Turkey Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Medical Isotopes Market Size YoY Growth (2018-2029) & (US$ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings